Abstract | OBJECTIVE: METHODS:
Estradiol-supplemented intact and ovariectomized immunodeficient mice were implanted with BT-474 cells. Progestin pellets were implanted simultaneously with estradiol pellets either 2 days before tumor cell injection (ie, combined) or 5 days after tumor cell injections (ie, sequentially). RESULTS: CONCLUSIONS:
|
Authors | Yayun Liang, Indira Benakanakere, Cynthia Besch-Williford, Ryyan S Hyder, Mark R Ellersieck, Salman M Hyder |
Journal | Menopause (New York, N.Y.)
(Menopause)
2010 Sep-Oct
Vol. 17
Issue 5
Pg. 1040-7
ISSN: 1530-0374 [Electronic] United States |
PMID | 20461021
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Progesterone Congeners
- Norgestrel
- Norethindrone
|
Topics |
- Animals
- Breast Neoplasms
- Cell Line, Tumor
- Disease Models, Animal
- Female
- Hormone Replacement Therapy
(adverse effects)
- Lymphatic Metastasis
- Mice
- Mice, Nude
- Norethindrone
(pharmacology)
- Norgestrel
(pharmacology)
- Progesterone Congeners
(pharmacology)
- Transplantation, Heterologous
|